Alan Hennessy

Alan Hennessy currently serves as the Discovery and Exploratory Research Team Lead at the Global Antibiotic R&D Partnership (GARDP) since June 2023. Prior to this role, Alan Hennessy held various leadership positions at Syngenta from March 2011 to June 2023, including Group Leader and Head of Lead Generation, where responsibilities encompassed oversight of lead generation efforts. Alan Hennessy's earlier experience at GSK from November 2001 to March 2011 involved management of medicinal chemistry teams focused on antibacterial research, including the invention of Gepotidacin, which is in Phase III clinical trials. Academic qualifications include a PostDoc in Organic Synthesis from Imperial College London and a PhD in Asymmetric Catalysis from University College Dublin, where Alan Hennessy also earned a BSc (Hons) in Chemistry.